News - Dr Reddy's Laboratories, Mergers & Acquisitions


Popular Filters

India's Dr Reddy's to acquire OctoPlus for $35.7 million


India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) announced this morning that it intendeds…

Dr Reddy's LaboratoriesGenericsMergers & AcquisitionsOctoPlusPharmaceutical

Battle for Afexa escalates as suitors Valeant and Paladin up offers; Dr Reddy’s and JBCPL scrap Russian deal


The fight for the acquisition of Canada’s Afexa Life Sciences (TSX: FXA) has gone into overdrive,…

Afexa Life SciencesDr Reddy's LaboratoriesJB Chemicals & PharmaceuticalsLicensingMergers & AcquisitionsPaladin LabsPharmaceuticalValeant Pharmaceuticals

Back to top